Research.Patient.info

Relapsed/Refractory B-cell Malignancies research hub

1 indexed studies · 0 currently recruiting

ongoing, recruitingHuman Pharmacology (Phase I)- First administration to humans
A Study to Learn More About an Investigational Medicine called HDP-102 in Patients with Relapsed/Refractory B-cell Blood Cancers.
This study is looking into a new medicine, HDP-102, for people with B-cell blood cancers that have come back or not responded to previous treatments. It's an early-stage study to understand how the medicine works and if it's safe.
Romania · Poland · Spain